Teladoc Health, Inc. $TDOC Shares Sold by Northern Trust Corp

Key Points

• Northern Trust Corp has reduced its stake in Teladoc Health, Inc. by 4.0%, now owning approximately $12.83 million worth of shares.
• Institutional investors collectively own 76.82% of Teladoc Health's stock, indicating strong interest from large financial firms.
• Teladoc Health reported a net loss in its latest earnings results, with a revenue decline of 1.6% year-over-year, despite beating EPS estimates.

Northern Trust Corp reduced its position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 4.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,612,020 shares of the health services provider's stock after selling 67,362 shares during the quarter. Northern Trust Corp owned approximately 0.92% of Teladoc Health worth $12,832,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of TDOC. Golden State Wealth Management LLC grew its position in Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after acquiring an additional 1,690 shares in the last quarter. National Bank of Canada FI grew its position in Teladoc Health by 79.4% in the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock valued at $28,000 after acquiring an additional 1,581 shares in the last quarter. Westside Investment Management Inc. grew its position in Teladoc Health by 16.8% in the 1st quarter. Westside Investment Management Inc. now owns 10,750 shares of the health services provider's stock valued at $86,000 after acquiring an additional 1,550 shares in the last quarter. Brucke Financial Inc. acquired a new position in Teladoc Health in the 4th quarter valued at about $92,000. Finally, AE Wealth Management LLC purchased a new position in shares of Teladoc Health in the 1st quarter valued at about $93,000. 76.82% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on TDOC. Bank of America decreased their price objective on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research note on Wednesday, May 28th. Evercore ISI lifted their price objective on Teladoc Health from $7.00 to $8.00 and gave the company an "in-line" rating in a research note on Wednesday, July 9th. Mizuho began coverage on Teladoc Health in a research note on Friday, July 25th. They issued a "neutral" rating and a $10.00 price objective for the company. Finally, Truist Financial decreased their price objective on Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a research note on Tuesday, May 27th. Six research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat, Teladoc Health presently has an average rating of "Hold" and an average price target of $9.80.

Teladoc Health Stock Performance

TDOC traded down $0.11 during trading on Tuesday, hitting $7.74. 2,688,606 shares of the stock were exchanged, compared to its average volume of 6,787,912. The firm has a market capitalization of $1.37 billion, a P/E ratio of -6.51 and a beta of 1.84. Teladoc Health, Inc. has a 1-year low of $6.35 and a 1-year high of $15.21. The stock has a fifty day moving average price of $7.76 and a two-hundred day moving average price of $7.76. The company has a quick ratio of 2.58, a current ratio of 2.67 and a debt-to-equity ratio of 0.70.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.08. The company had revenue of $631.90 million for the quarter, compared to analyst estimates of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The firm's revenue was down 1.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.38) earnings per share. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. As a group, sell-side analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.